Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations
Hafiz Muhammad Ali(Laboratoire de Vectorologie et Thérapeutiques Anticancéreuses), Liliane Massaad-Massade(Inserm)
Cited by 17
Related Papers
Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A
|Communications Biology|2021|60
Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer
|PLoS ONE|2015|35
Induction of TTF-1 or PAX-8 expression on proliferation and tumorigenicity in thyroid carcinomas
|International Journal of Oncology|2016|34